Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort studyMads Israelsen, Aleksander Krag, Camilla Dalby Hansen et al.|The Lancet. Gastroenterology & hepatology|2024Cited by 152
Screening for Fibrosis Promotes Lifestyle Changes: A Prospective Cohort Study in 4796 IndividualsMaria Kjærgaard, Maja Thiele, Camilla Dalby Hansen et al.|Clinical Gastroenterology and Hepatology|2023Cited by 54
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort studyKatrine Prier Lindvig, Maja Thiele, Camilla Dalby Hansen et al.|The Lancet. Gastroenterology & hepatology|2024Cited by 35
Steatotic Liver Disease Classification Is Dynamic, Affecting Clinical Trial Eligibility and Subclass-Specific TreatmentsMads Israelsen, Aleksander Krag, Camilla Dalby Hansen et al.|Clinical Gastroenterology and Hepatology|2025Cited by 33
Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intakeEmil Deleuran Hansen, Mads Israelsen, Camilla Dalby Hansen et al.|JHEP Reports|2024Cited by 29